Artificial Intelligence for the Future of Pharmacovigilance in Pakistan: Barriers, Opportunities, and Comparison with Other Low and Middle-Income Countries

Artificial intelligence (AI) is progressing day by day, and with it, the number of unreported adverse drug reactions (ADRs) linked to inadequate pharmacovigilance (PV) in Pakistan is increasing. PV is defined as the science of identifying, evaluating, and preventing side effects or other drug-related issues in order to make sure that the advantages of medications balance the risks over the course of their whole lifecycle. It has been estimated that more than 75% of healthcare professionals display poor practices when it comes to reporting ADRs. However, the majority of them, in principle, have a positive attitude towards reporting. In comparison, self-medication completely bypasses the formal system and is carried out by over 61.2% of the population in certain samples. Ongoing problems such as underreporting, insufficient professional awareness, a fragmented infrastructure, and linguistic diversity continue to limit the country's ability to identify medication-related harm on a large scale. Internationally, AI has been suggested as a means of overcoming this gap by enabling real-time detection of ADRs, using predictive analytics, and automatically extracting adverse events from unstructured clinical text. This narrative review brings together the available evidence on Pakistan's current PV system, compares its performance with that of other low- and middle-income countries (LMICs) using the World Health Organization (WHO) Indicator-based Pharmacovigilance Assessment Tool (IPAT), and sets out a route for the implementation of AI-assisted PV. We drew on evidence from AI-based pharmacovigilance studies in low-resource settings, research using electronic health records, and a controlled trial of a mobile ADR-reporting application in Uganda to identify strategies relevant to Pakistan. Based on this evidence, the immediate priority should be to build sound policies and a qualified workforce rather than focusing on advanced modelling. Once these foundations are in place, lightweight, text-based AI interventions can be introduced in settings where drug exposure already takes place. Hence, this review also proposes a three-tier implementation roadmap based on Pakistan’s local context and evidence from other LMICs. The roadmap aims to align the growing use of these technologies with the regulatory and health-system constraints within which they must be implemented.

Authors

Institutions

Publication Details

Journal
International journal of trends in pharmaceutical and chemical research.
Published
2026-11-20
DOI
https://doi.org/10.61980/3049-7639/2026/4/40
Primary Topic
Pharmacovigilance and Adverse Drug Reactions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Artificial Intelligence for the Future of Pharmacovigilance in Pakistan: Barriers, Opportunities, and Comparison with Other Low and Middle-Income Countries

Ashmal Aslam, Ezma Khan
International journal of trends in pharmaceutical and chemical research.
Pharmacovigilance and Adverse Drug Reactions
article

Artificial Intelligence for the Future of Pharmacovigilance in Pakistan: Barriers, Opportunities, and Comparison with Other Low and Middle-Income Countries

Ashmal Aslam, Ezma Khan
article en

Abstract

Artificial intelligence (AI) is progressing day by day, and with it, the number of unreported adverse drug reactions (ADRs) linked to inadequate pharmacovigilance (PV) in Pakistan is increasing. PV is defined as the science of identifying, evaluating, and preventing side effects or other drug-related issues in order to make sure that the advantages of medications balance the risks over the course of their whole lifecycle. It has been estimated that more than 75% of healthcare professionals display poor practices when it comes to reporting ADRs. However, the majority of them, in principle, have a positive attitude towards reporting. In comparison, self-medication completely bypasses the formal system and is carried out by over 61.2% of the population in certain samples. Ongoing problems such as underreporting, insufficient professional awareness, a fragmented infrastructure, and linguistic diversity continue to limit the country's ability to identify medication-related harm on a large scale. Internationally, AI has been suggested as a means of overcoming this gap by enabling real-time detection of ADRs, using predictive analytics, and automatically extracting adverse events from unstructured clinical text. This narrative review brings together the available evidence on Pakistan's current PV system, compares its performance with that of other low- and middle-income countries (LMICs) using the World Health Organization (WHO) Indicator-based Pharmacovigilance Assessment Tool (IPAT), and sets out a route for the implementation of AI-assisted PV. We drew on evidence from AI-based pharmacovigilance studies in low-resource settings, research using electronic health records, and a controlled trial of a mobile ADR-reporting application in Uganda to identify strategies relevant to Pakistan. Based on this evidence, the immediate priority should be to build sound policies and a qualified workforce rather than focusing on advanced modelling. Once these foundations are in place, lightweight, text-based AI interventions can be introduced in settings where drug exposure already takes place. Hence, this review also proposes a three-tier implementation roadmap based on Pakistan’s local context and evidence from other LMICs. The roadmap aims to align the growing use of these technologies with the regulatory and health-system constraints within which they must be implemented.

International journal of trends in pharmaceutical and chemical research.
University of Karachi (PK)
Pharmacovigilance and Adverse Drug Reactions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon